iNKT accumulation aggravates NASH through a pallet of cytokines that change over time: IL-17+ and IL-22+ iNKT cells emerged at the onset of disease, while IL-4+ and IL-13+ iNKT increased later in disease pathogenesis (91). The gene discussed is IL17A; the disease is metabolic dysfunction-associated steatohepatitis.